NCT03920111View on ClinicalTrials.gov

Flavivirus Cross-priming Potential of IMOJEV

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 16, 2021

Primary Completion Date

December 23, 2021

Study Completion Date

May 11, 2022

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

IMOJEV

live attenuated Japanese encephalitis (JE) vaccine IMOJEV®

Trial Locations (1)

L7 8XP

Liverpool University Hospitals NHS Foundation Trust, Liverpool

All Listed Sponsors
lead

University of Liverpool

OTHER